<DOC>
	<DOCNO>NCT00418730</DOCNO>
	<brief_summary>The purpose study measure hair growth response topical NEOSH101 apply twice daily bald scalp 16 week . One hundred eighty men Norwood/Hamilton grade III-IV thin top center scalp participate . Three equally size treatment group ( 60 men ) receive either topical NEOSH101 2.0 % , minoxidil 5 % , placebo .</brief_summary>
	<brief_title>Efficacy Study Topical NEOSH101 Treat Male Pattern Hair Loss</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Proteasome Inhibitors</mesh_term>
	<criteria>Caucasian men , general good health , age 1849 year Norwood/Hamilton grade IIIIV , thin hair vertex area concomitant dermatologic medical condition ( ) may interfere investigator 's ability evaluate subject 's response study drug treatment systemic locally act medication may interfere study objective , minoxidil treatment 6 month prior study start , finasteride treatment 12 month prior study start , treatment investigational hair growth product 6 month prior study start</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>androgenetic alopecia</keyword>
	<keyword>male pattern hair loss</keyword>
	<keyword>male pattern baldness</keyword>
	<keyword>androgenetic alopecia male pattern hair loss</keyword>
</DOC>